Dr. Basche is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10107 Ridgegate Pkwy
Ste 200
Littleton, CO 80124Phone+1 303-930-7800Fax+1 303-930-7860- Is this information wrong?
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2000 - 2002- University of ColoradoFellowship, Geriatric Medicine (Internal Medicine), 1999 - 2000
- University of ColoradoResidency, Internal Medicine, 1996 - 1999
University of California San Francisco School of MedicineClass of 1996
Certifications & Licensure
CO State Medical License 1998 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- EMD 121974 in Treating Patients With Advanced Solid Tumors Start of enrollment: 2001 May 01
- Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 Apr 01
Publications & Presentations
PubMed
- 40 citationsA multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors.Gayle S. Jameson, John T. Hamm, Glen J. Weiss, Carlos Alemany, Stephen P. Anthony, Michele Basche, Ramesh K. Ramanathan, Mitesh J. Borad, Raoul Tibes, Allen Lee Cohn, ...> ;Clinical Cancer Research. 2013 Jan 1
- 9 citationsPhase I combination study of trabectedin and capecitabine in patients with advanced malignanciesLia Gore, E. Rivera, Michele Basche, S. L. Moulder-Thompson, J. Li, S. Eppers, S. Grolnic, Cindy L. O'Bryant, D. Cleere, Y. A. Elsayed, S. G. Eckhardt> ;Investigational New Drugs. 2012 Oct 1
- 3 citationsA dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in...Cindy L. O'Bryant, Christopher H. Lieu, Stephen Leong, Ramesh Boinpally, Michele Basche, Lia Gore, K. Leonardi, Mary Kay Schultz, S. Hariharan, Laura Q M Chow, Sami Di...> ;Cancer Chemotherapy and Pharmacology. 2009 Feb 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Rose Medical CenterDenver, Colorado
Sky Ridge Medical CenterLone Tree, Colorado- St Anthony North Medical PavilionBroomfield, Colorado
AdventHealth PorterDenver, Colorado
AdventHealth Castle RockCastle Rock, Colorado
AdventHealth AvistaLouisville, Colorado
AdventHealth ParkerParker, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
